Drug Patent Watch

FEBRUARY 13, 2025

They might involve collaborations between pharmaceutical companies, research institutions, and regulatory agencies. Or, they might involve partnerships between industry players and academia, where the latest research and expertise are combined to drive innovation.

Drug Development 72

Drug Development Drugs Pharmaceutical Companies Treatment 72

Eye on FDA

SEPTEMBER 28, 2022

FDA published notice recently that the Office of Prescription Drug Promotion (OPDP) was proposing some new research related to the promotion of medicines by pharmaceutical companies. The research was new (kind of) but the direction was more of the same old focus – direct-to-consumer advertising (DTC).

Research 69

Research Pharmaceutical Companies FDA Production 69

SCIENMAG: Medicine & Health

AUGUST 2, 2023

The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines.

Pharmaceutical Companies 83

Pharmaceutical Companies Pharmaceuticals Research Science 83

Quanticate

SEPTEMBER 27, 2024

Advancements in preclinical and clinical research are driving major changes across various therapeutic areas, steering the industry into a new phase of medical innovation. Our aim is to provide valuable insights for industry professionals, stakeholders, and all those invested in the future of medical science.

Clinical Research 52

Clinical Research Research Pharmaceutical Companies Science 52

Drug Patent Watch

FEBRUARY 27, 2025

Imagine investing years of research and development into a groundbreaking new medication, only to see it copied and sold in foreign markets without your permission. This is a nightmare scenario for any pharmaceutical company, and it's a reality that many face every day.

Marketing 52

Marketing Drugs Regulations Pharmaceutical Companies 52

Drug Patent Watch

JANUARY 21, 2025

From identifying and prioritizing patent opportunities to leveraging data and analytics, we'll explore the strategies that top pharmaceutical companies are using to stay ahead of the curve. In our latest blog post, we dive into the best practices for drug patent portfolio management.

Drugs 54

Drugs Pharmaceutical Companies Pharmaceuticals Marketing 54

DrugBank

MARCH 7, 2024

Pharmaceutical researchers, in particular, have a keen interest in understanding the unfolding dynamics of this market. Inspired by its success, pharmaceutical companies are pursuing the development of drugs with similar therapeutic profiles, aiming to expand treatment options.

Pharmaceutical Companies 98

Pharmaceutical Companies Clinical Trials Pharmaceuticals Therapies 98

Cytel

MARCH 3, 2023

The speed of scientific discovery has been outpacing the ability of researchers to accumulate and integrate constantly evolving new insights into systematic literature reviews (SLRs). This gets compounded by obstacles to accessing the newest publications. Was it possible?

Research 52

Research Pharmaceutical Companies Pharmaceuticals Clinical Development 52

Drug Channels

AUGUST 12, 2022

Divya highlights new GoodRx research on the out-of-pocket cost gap between brand-name and generic prescriptions. Divya then explains how GoodRx partners with pharmaceutical companies to improve cost transparency and communication between patients and providers.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Drugs Research 96

PPD

JUNE 20, 2024

Acceleration in every step of clinical research is critical to pharmaceutical developers. Yet, today’s clinical research sponsors face significant challenges. Rather than accepting the persistent delays in clinical research as disruptive, yet unavoidable, we believe they underscore the need for greater efficiency.

Clinical Research 52

Clinical Research Research Clinical Trials Pharmaceuticals 52

Crown Bioscience

MAY 4, 2021

Crown Bioscience Director Mike Batey takes a closer look at pediatric cancer and how recent regulatory changes and additional research focus may deliver new therapies for kids. In August 2020, new US legislation was passed which promises to have a major influence on the way companies approach pediatric drug development.

Research 52

Research Pharmaceutical Companies Licensing Licensing 52

Drug Target Review

MARCH 4, 2025

Phenomix Sciences, built on over a decade of clinical research at the Mayo Clinic, is disrupting this outdated approach. The research demonstrated that obesity is not one disease, but many; each of which should be treated with different interventions, says Bagnall. These individuals respond four times better to GLP-1 medications.

Therapies 52

Therapies Treatment Clinical Trials Science 52

Conversations in Drug Development Trends

DECEMBER 7, 2023

Amidst a shifting clinical landscape characterized by increasingly complex trial designs and growing patient subpopulations, many contract research organizations (CROs) have adopted a “one-stop-shop” strategic approach. What Differentiates Mid-Size CROs? To learn more about our end-to-end services, contact us today.

Clinical Trials 136

Clinical Trials Clinical Development Trials Pharmaceutical Companies 136

DrugBank

MARCH 15, 2024

The weight loss industry has emerged as a major hub for innovative research, groundbreaking treatments, and economic opportunity. According to Grand View Research , the global weight loss and weight management market size was valued at $142.5 This has caused a great deal of hesitation from pharmaceutical companies in the past.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceuticals Treatment Clinical Trials 97

Broad Institute

NOVEMBER 14, 2023

He’s been involved in every stage of the process, including managing the 10 pharmaceutical companies and two nonprofit organizations contributing to the database, designing experiments, and creating data analysis pipelines. I never thought I’d be able to do research on my own. What does an average day look like for you?

Science 115

Science Pharmaceutical Companies Pharmaceuticals Engineering 115

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Clinical Research 98

Clinical Research Pharmaceutical Companies Clinical Development Drug Development 98

Drug Target Review

AUGUST 6, 2024

The availability of well-characterised targets is essential and oncology benefits from extensive research identifying tumour-specific antigens, making it a fertile ground for ADC development. Portfolio diversification is another strategy, with companies investing in multiple therapeutic areas to balance risk and maximise opportunities.

Therapies 119

Therapies Pharmaceutical Companies Disease Treatment 119

Molecule Blog

MARCH 17, 2023

Moving research from concept to market is like conducting a symphony — there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project. Funding typically comes from a mix of government agencies, venture capitalists (VCs), and pharmaceutical companies.

Engineering 52

Engineering Research Clinical Trials Government 52

ACTO

DECEMBER 17, 2024

Yet, the critical question remains: How can pharmaceutical companies ensure responsible and compliant AI implementation while maximizing its potential for field teams? In addition, 33% of them are currently piloting different solutions in sales, and 44% plan to adopt AI in sales in the next 24 months.

Government 52

Government Compliance Pharmaceutical Companies Pharmaceuticals 52

Drug Target Review

MARCH 3, 2025

His research focuses on creating advanced cell culture models, such as brain organoids and assembloids, derived from patient-specific stem cells. In this interview, Professor Schwamborn discusses his research, the promise of brain organoids, and his vision for the future of stem cell-based therapies.

Disease 52

Disease Treatment Therapies Cell Biology 52

The Pharma Data

NOVEMBER 29, 2020

Headquarters: Cambridge, UK, “Wren”) today announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery of novel small molecules that target ?-synuclein is a leading global research and development-based pharmaceutical company headquartered in Japan.

Small Molecule 52

Small Molecule Research Pharmaceutical Companies Drugs 52

Drug Target Review

JANUARY 8, 2024

We are at the forefront of drug development in an area of research called cellular rejuvenation, which is an approach that has the potential to address many diseases of ageing by restoring aged and injured cells to a more youthful and resilient state. a commercial stage pharmaceutical company.

Science 145

Science Disease FDA Approval Clinical Trials 145

The Pharma Data

NOVEMBER 25, 2020

In the course of the strategic research alliance that was announced in June 2020, Egle will validate novel tumor-infiltrating regulatory T-cell (Treg) targets against which Takeda will develop potential therapies.

Research 52

Research Bioinformatics Pharmaceutical Companies Engineering 52

The Pharma Data

APRIL 6, 2021

Bayer will present new research across its oncology portfolio at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021 , taking place over two weeks on April 10-15 and May 17-21, 2021. The product is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.

Research 52

Research Small Molecule Treatment Clinical Trials 52

Broad Institute

DECEMBER 18, 2023

Brain disorders are difficult to study and many drug candidates have failed in clinical trials, causing pharmaceutical companies to reduce their investments or even exit the field entirely. But a new path for bringing treatments to patients is starting to emerge. We all recognize the vast, unmet medical need. Can you expand on that?

Drug Development 130

Drug Development Clinical Trials Drugs Disease 130

DrugBank

OCTOBER 4, 2024

Emerging Markets Emerging markets, particularly in Asia and Latin America, have become increasingly attractive destinations for pharmaceutical M&A activity. The growing middle class and government initiatives to improve access to medicines have created an ecosystem for pharmaceutical companies seeking growth opportunities.

Pharmaceuticals 98

Pharmaceuticals Pharmaceutical Companies Therapies Marketing 98

DrugBank

OCTOBER 17, 2024

By harnessing the vast amounts of data generated throughout the development pipeline, pharmaceutical companies can accelerate the discovery of novel therapies, optimize clinical trial design, enhance drug safety monitoring, and deliver personalized medicine, ultimately improving patient outcomes and transforming the future of healthcare.

Drug Development 98

Drug Development Metabolic Stability Clinical Trials Drugs 98

KIF1A

JULY 1, 2023

Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Using similar logic, researchers measured the movement of KIF1A homodimers (a pair of healthy KIF1A motors, or a pair of mutant KIF1A motors).

Small Molecule 98

Small Molecule FDA Approval Disease Pharmaceutical Companies 98

Eye on FDA

AUGUST 2, 2022

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

Pharmaceutical Companies 88

Pharmaceutical Companies FDA Pharmaceuticals Drugs 88

Molecule Blog

JANUARY 9, 2023

The future of research is collaborative, digital, and highly autonomous. Research is built on data (and sometimes code) that routinely isn’t shared, affecting our ability to replicate science. Researchers make proposals to the system for projects that contribute to solving the disease. Patents today are not.

Research 52

Research Licensing Licensing Science 52

The Pharma Data

NOVEMBER 13, 2020

November 14, 2020 – Johnson & Johnson (the Company) announced the expansion to the partnership between its Janssen Pharmaceutical Companies (Janssen) and the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S.

Vaccine 40

Vaccine Pharmaceutical Companies Research Pharmaceuticals 40

Drug Target Review

DECEMBER 11, 2024

As a contract research organisation, we have supported numerous clients in overcoming matrix interference, particularly small and emerging biotherapeutics developers who may lack the in-house expertise to navigate such complex problems. This highlights its vital role in modern biotherapeutic research.

International 52

International Laboratories Drugs Pharmacokinetics 52

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

H1 Blog

DECEMBER 4, 2023

With the help of digital health platforms, researchers have access to vast amounts of data that can be analyzed to identify potential participants from underrepresented communities. For example, using geographical data, researchers can map areas with higher prevalence rates of certain diseases and target those communities for recruitment.

Clinical Trials 59

Clinical Trials Trials Pharmaceutical Companies Drug Development 59

DrugBank

JUNE 27, 2024

These candidates can be broadly classified into two categories: serendipitous discoveries and those identified through targeted research on a drug's MoA. Research infrastructure also presents hurdles. Challenges of Drug Repurposing Drug repurposing shows a great deal of promise but it isn’t without its challenges.

Drugs 98

Drugs Pharma Companies Clinical Trials Computational Chemistry 98

DrugBank

APRIL 12, 2024

While academic research pushes the boundaries of what's possible, translating these findings into viable commercial solutions entails a host of operational, financial, and regulatory considerations.

Drugs 98

Drugs Clinical Trials Pharmaceutical Companies Pharmaceuticals 98

Conversations in Drug Development Trends

APRIL 4, 2024

Understanding and implementing the ICH M10 guidelines is not just a regulatory requirement; it’s a step towards more efficient and effective pharmaceutical research.

Small Molecule 80

Small Molecule Clinical Trials Pharmaceuticals Pharmaceutical Companies 80